Mesenteric panniculitis

1. Mesentericpanniculitis BEN ROMDHANE MH Hopital AVICENNE BOBIGNY

2. Mesenteric panniculitis • inflammatory disorder of the fatty tissue of the bowel mesentery • Uncommon • several names(resulting in considerable confusion ): lipodystrophy, mesenteric Weber-Christian disease, fibrosing mesenteritis, sclerosing mesenteritis retractile mesenteritis

3. varied terminology reflects the pathological spectrum • now considered to be one single disease • chronic nonspecific inflammatory process in the mesentery • rarely may lead to fibrosis and retraction • If inflammation predominates over fibrosis the process is known as mesenteric panniculitis • when fibrosis and retraction predominate, terms: fibrosingmesenteritis, retractile mesenteritis or sclerosingmesenteritis are more commonly used

4. MP supposed to be very rare, approximately 250 cases reported in the literature • With increased use of abdominal diagnostic imaging, MP is diagnosed more often • Recently reported prevalence of 0.6% of all patients undergoing an abdominal CT for various indications

5. Pathogenesis • infiltration of mesenteric fat by : inflammatory cells, mainly lymphocytes and fat-laden macrophages • with inflammation, a mixture of fat necrosis and fibrosis may be present in the mesentery • exact cause remains unclear

6. MP occurs independently or in association with other disorders • A variety of possible causative factors have been proposed: autoimmune disorders ischemia prior abdominal surgery

7. also suggested paraneoplastic response • This possible association with a concomitant malignancy highlighted in a study by Daskalogiannaki • reporting the presence of a coexisting abdominal or distal malignancy in 69% of patients with CT features of MP • In other studies prevalence of malignancy not different from general population of patients undergoing CT for all various indications

8. Clinical characteristics • mostly middle or late adulthood, • male predominance. • Clinical manifestations may be related to the inflammation or to mass-effect • Presenting symptoms may vary • may also be entirely asymptomatic • commonly include non-specific abdominal pain • Palpable abdominal mass may be present may lead to the clinical misdiagnosis (aortic aneurysm ...)

9. Laboratory findings: often within the normal range or demonstrate non-specific findings: mild leucocytosis and elevation of the erythocyte sedimentation rate. • before the advent of modern diagnostic imaging, MP was diagnosed exclusively as an unexpected finding at exploratory laparotomy or autopsy

10. Diagnosis • A definite diagnosis of MP can be made only by pathologic analysis • However, the incidental benign and often asymptomatic nature of MP usually does not justify biopsy • In these cases, diagnosis may be suggested by characteristic imaging features from the radiological literature from pathologically proven cases

11. US features • often quite subtle may be easily overlooked • poorly defined hyperechoic change of the mesenteric fat • decrease in mesenteric compressibility • may be seen in various conditions with mesenteric involvement( lipomatoustumors... • CT always recommended to analyze any US-found mesenteric abnormalities

12. A. C. van Breda Vriesman Eur Radiol (2004)

13. CT features • increased density of mesenteric fatty tissue (approximately− 40 to −60 HU) compared to the attenuation values of normal retroperitoneal or subcutaneous fat (−100 to −160 HU) • hyperattenuating fat surrounds mesenteric vessels • but does not displace them • some regional mass-effect by displacing locally small bowel loops • mass most frequently located at the left side corresponding to jejunal mesentery

16. Piessen G Annales de chirurgie 131 2006

17. Other CT features reported • may be valuable clues for the diagnosis: the fat-ring sign, tumoral pseudocapsule soft-tissue nodules

18. Fat-ringsign • Fat-ring sign or “fatty halo 75–85% • low-density fat surrounding vessels and nodules • preservation of normal fat density, corresponding to unaffected noninflamed fat interposed between vessels or nodules and inflammatory cells at histopathology • non-specific • also reported incidentally in non-Hodgkin’s lymphoma in which chemotherapy treatment has led to reduction of the mesenteric lymphadenopathy, leaving a fine haziness throughout the mesenteric fat

20. Tumoralpseudocapsule • peripheral band with soft-tissue attenuation limiting the inflammatory mesenteric mass • thickness of this dense stripe usually does not exceed 3 mm • reported in 50–59% of patients • lipomatoustumor (lipoma or liposarcoma) may be well-defined by a similar dense rim • but these lesions will often show some mass-effect on the mesenteric vessels in contrast to M P

21. A. C. van Breda Vriesman Eur Radiol (2004)

23. Soft-tissuenodules • small soft-tissue nodules scattered within the hyperattenuating mesenteric mass • in 80% of cases • Correspond probably to lymph nodes • usually less than 5 mm in diameter • Mesenteric lymph nodes larger than 10 mm atypical for MP • biopsy or fine-needle aspiration must be considered to exclude malignancy

24. SM • most commonly appears as a soft-tissue mass in the small bowel mesentery • The mass may envelop the mesenteric vessels, and collateral vessels • Mesenteric thickening and fibrosis often with nodular masses involving the appendices epiploicae of the colon

27. Calcification may be present, usually in the central necrotic portion of the mass • it may be related to the fat necrosis • Cystic components also described • may be the result of lymphatic or venous obstruction and necrotic change • Enlarged mesenteric or retroperitoneal lymph nodes may be present

28. Farzana Nawaz Ali, Case Reports in Medicine2010

29. Farzana Nawaz Ali, Case Reports in Medicine 2010

30. Imaging-based differential diagnosis • misty mesentery :Alteration in the density of the mesenteric fat on CT • with an extensive differential diagnosis • MP reserved for idiopathic inflammation leading to a misty mesentery

33. imaging diagnosis can therefore be made only after exclusion of any of the following alternative causes of a misty mesentery

34. Mesenteric edema • Many causes • heart failure, portal hypertension, mesenteric vascular thrombosis and lymphedema. • mesenteric edema secondary to a systemic disease, usually associated with generalized subcutaneous edema and ascites. • Ascites is not a feature of MP and indicates an alternative diagnosis

35. Inflammation • acute pancreatitis is the typical inflammatory process associated with increased CT density of the mesenteric fat • usually centered in the peripancreatic region • With usually increased levels of amylase in serum and urine enabling the diagnosis • Focal inflammations such as appendicitis and colonic diverticulitis may also cause local hyperattenuation of adjacent mesenteric fat • these diagnoses must be carefully ruled out

37. Mesenteric Hemorrhage • hemorrhage, caused by blood dissecting from mesenteric vessels or from the bowel wall • may be traumatic or spontaneous • A history of trauma, use of anticoagulantia • or high-density peritoneal fluid suggests the correct diagnosis

39. Neoplasm • Non-Hodgkin’s lymphoma most common mesentery tumor • Typically bulky lymphadenopathy, • often also n the retroperitoneum, indicating the correct diagnosis • Shrinkage of mesenteric lymphadenopathy after chemotherapy may result in residual scarring that may mimic MP • Needs reviewing the patient’s prior CT scans

40. lymphoma manifested as nodal mass in the root of the mesentery may mimic SM • no calcification unless previously treated • Both can encase mesenteric vasculature • lymphoma almost never result in ischemia • fat halo sign favors a diagnosis of SM • large, nodes favor lymphoma • Treated lymphoma may also produce a misty mesentery simulating the MP

44. Primary mesenteric neoplasms (desmoid, mesenteric cyst, lipomatous tumors) cause mass-effect on mesenteric vessels • Other tumors :mesothelioma, or metastatic tumors:( pancreatic, colon or ovarian carcinoma ) may affect the mesentery by soft-tissue tumor deposits, or may cause mesenteric edema by lymphatic obstruction • correct diagnosis made by identification of the primary tumor or detection of extra-mesenteric peritoneal nodules, or by cytological analysis of ascites

45. A. C. van Breda Vriesman Eur Radiol (2004)

46. Carcinoid tumor may simulate SM • ill-defined, infiltrating soft-tissue mass in the root of the mesentery with calcification and desmoplastic reaction • fat ring sign favors a diagnosis of SM • enhancing mass in bowel wall or hypervascular liver metastases : sign diagnosis of carcinoid tumor

47. primary mesenteric mesothelioma can produce mesenteric soft-tissue implants in mesentery, also seen in the omentum and along the bowel surfaces. • Ascites not associated with SM • Calcification not common

48. Treatment • Treatment usually empirical • may consist of steroids, colchicine, immunosuppressive agents, or orally administered progesterone • In SM Surgical resection difficult due to vessel compromise may be of no clear benefit • colostomy may be necessary with colonic involvement by SM

49. Variable course With treatment: relatively benign course progression of the disease eventually leads to death In some cases, complete resorption

50. CT suggest the diagnosis of SM • CT useful in distinguishing SM from other mesenteric diseases such as lymphoma or carcinoid tumor • Biopsy necessary for SM diagnosis • CT optimal study for the follow up